申请人:Eli Lilly and Company
公开号:US04029671A1
公开(公告)日:1977-06-14
There are disclosed novel 3-[(5-nitro-2-imidazolyl)pyrazol-5-yl]oxamic acid derivatives and salts thereof, exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of cattle, swine, and poultry.
本文披露了新型3-[(5-硝基-2-咪唑基)吡唑-5-基]羟肟酸衍生物及其盐,具有抗菌、抗原虫和抗真菌作用,使得这些化合物在兽医学中尤其有用,特别是在控制牛、猪和家禽的细菌和原虫感染方面。